BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18362281)

  • 21. The association of incident dementia with mortality in PD.
    Jellinger K
    Neurology; 2003 Aug; 61(3):424. PubMed ID: 12913222
    [No Abstract]   [Full Text] [Related]  

  • 22. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
    Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.
    Liu CC; Sun Y; Lee PC; Li CY; Hu SC
    BMJ Open; 2019 Mar; 9(3):e025274. PubMed ID: 30833322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in dementia-free life expectancy among elderly members of a large health maintenance organization.
    Sauvaget C; Tsuji I; Haan MN; Hisamichi S
    Int J Epidemiol; 1999 Dec; 28(6):1110-8. PubMed ID: 10661655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson disease survival: a population-based study.
    Morgante L; Salemi G; Meneghini F; Di Rosa AE; Epifanio A; Grigoletto F; Ragonese P; Patti F; Reggio A; Di Perri R; Savettieri G
    Arch Neurol; 2000 Apr; 57(4):507-12. PubMed ID: 10768625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Burning Mouth Syndrome and the Development of Depression, Anxiety, Dementia, and Parkinson Disease.
    Kim JY; Kim YS; Ko I; Kim DK
    JAMA Otolaryngol Head Neck Surg; 2020 Jun; 146(6):561-569. PubMed ID: 32352482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study.
    Fuhrer R; Dufouil C; Dartigues JF;
    J Am Geriatr Soc; 2003 Aug; 51(8):1055-63. PubMed ID: 12890066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.
    Darweesh SK; Koudstaal PJ; Stricker BH; Hofman A; Ikram MA
    Am J Epidemiol; 2016 Jun; 183(11):1018-26. PubMed ID: 27188952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson disease with and without Dementia: A prevalence study and future projections.
    Savica R; Grossardt BR; Rocca WA; Bower JH
    Mov Disord; 2018 Apr; 33(4):537-543. PubMed ID: 29356127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study.
    Bjornestad A; Tysnes OB; Larsen JP; Alves G
    Neurology; 2016 Oct; 87(15):1599-1606. PubMed ID: 27590290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.
    Onofrj M; Bonanni L; Manzoli L; Thomas A
    Neurology; 2010 May; 74(20):1598-606. PubMed ID: 20479358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and remaining lifetime risk of Parkinson disease in advanced age.
    Driver JA; Logroscino G; Gaziano JM; Kurth T
    Neurology; 2009 Feb; 72(5):432-8. PubMed ID: 19188574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled study of dementia in Parkinson's disease over 54 months.
    Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG
    Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172
    [No Abstract]   [Full Text] [Related]  

  • 38. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
    Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Yoo HS; Chung SJ; Lee YH; Lee HS; Ye BS; Sohn YH; Lee PH
    Neurology; 2019 Mar; 92(13):e1468-e1478. PubMed ID: 30796137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality from Parkinson disease.
    Louis ED; Marder K; Cote L; Tang M; Mayeux R
    Arch Neurol; 1997 Mar; 54(3):260-4. PubMed ID: 9074394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.